Histaxpres-LM Tablet contains Levocetirizine 5mg and Montelukast 10mg, combining an antihistamine and a leukotriene receptor antagonist to provide effective relief from allergic conditions. Levocetirizine, a selective H1 receptor antagonist, alleviates symptoms such as sneezing, rhinorrhea, nasal congestion, and itching associated with allergic rhinitis and chronic urticaria by inhibiting the action of histamine. Montelukast, a leukotriene receptor antagonist, blocks leukotriene D4 at the cysteinyl leukotriene receptor, reducing bronchoconstriction, inflammation, and mucus production, thereby improving respiratory symptoms in asthma and allergic rhinitis. Histaxpres-LM is indicated for the management of seasonal and perennial allergic rhinitis, chronic idiopathic urticaria, and as an adjunct therapy in asthma to control symptoms and prevent exacerbations. The combination offers a dual mechanism of action targeting multiple pathways involved in allergic responses, enhancing symptom control and patient compliance. It is generally well tolerated; common adverse effects may include headache, fatigue, dry mouth, and gastrointestinal disturbances. Use with caution in patients with hepatic or renal impairment, and it is contraindicated in individuals hypersensitive to any component. Histaxpres-LM should be administered as prescribed by a healthcare professional, with dosage adjustments based on clinical response and patient condition.